TOP U-S COURT UNANIMOUSLY RULES GENES CANNOT BE PATENTED

Jun 13, 2013

By Michael Kramer

Share on

The U-S Supreme Court has ruled  companies cannot  patent  parts of naturally-occurring human genes.

The  unanimous judgment throws out patents held by Myriad Genetics  on an increasingly popular breast cancer test.

That  was brought to light recently by actress Angelina Jolie’s revelation  that she had a double mastectomy because of one of the genes involved in this case.

The court said that laws of nature, natural phenomena and abstract ideas are not patentable.

Myriad sells the only B-R-C-A gene test.

It uses DNA analysis to identify harmful changes in either one of  the two breast cancer susceptibility genes.

Opponents say the company can use the patents to keep other researchers from working with the B-R-C-A gene to develop other tests.

However, the court did rule that synthetically created DNA, known as c-DNA, can be patented -because it is not naturally occurring.

Join Our Fan Club
Coverage Area
Downtown Toronto
96.7FM
Toronto HD
96.3 HD-2
Kingston to Windsor, Parry Sound to Pittsburgh
AM740
ZoomerRadio Logo

Recently Played: